Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 168 record(s)

Req # A-2021-000617

All records over the period of 2019-10-01 through 2022-12-31 of the members : The Honourable Jean - Yves Duclos Minister of Health The Honourable Carolyn Bennett - Minister of Mental Health and Addictions and Associate Minister of Health Dr. Theresa Tam Chief - Public Health Officer of Canada Dr. Harpreet S. Kochhar - President of the Public Health Agency of Canada Kathy Thompson - Executive Vice-President of the Public Health Agency of Canada. I am seeking any information transferred over this time by these public servants surrounding the covid-19 issue on the following topic. Early covid treatment.

Organization: Public Health Agency of Canada

0 page(s)
January 2024

Req # A-2021-000633

The reports provided to the government of Manitoba or health agencies in Manitoba containing details on levels of covid-19 detection in wastewater. Date range would be March 2020 - January 27, 2022.

Organization: Public Health Agency of Canada

315 page(s)
January 2024

Req # A-2022-000040

Any reports or briefs or communications from the Public Health Agency of Canada (PHAC) to the federal Health Ministers office and to the President of PHAC summarizing the decision and circumstance in New Brunswick on the neurological syndrome of unknown cause between the dates of February 1st 2022 - May 1st 2022.

Organization: Public Health Agency of Canada

385 page(s)
January 2024

Req # A-2022-000324

All email communications between the Public Health Agency of Canada (PHAC) employees and employees of the United States Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) and Food and Drug Administration (FDA) in relation to COVID-19 and specifically on the topics of myocarditis, pericarditis, "heart inflammation", "infection-induced immunity", "post-infection immunity". Timeframe: January 2019 to February 1, 2022.

Organization: Public Health Agency of Canada

599 page(s)
January 2024

Req # A-2023-000133

All records related to the Inquiry of Ministry/Question No. Q-1482 from Mr. Colin Carrie.

Organization: Public Health Agency of Canada

20 page(s)
January 2024

Req # A-2023-000163

Any records about the compound Erythrosine, including any potential health impacts on public health in Canada, and any potential reference to the recent regulatory actions taken by the State of California and the United States Food and Drug Administration. Date range November 4, 2015 to December 27, 2024.

Organization: Public Health Agency of Canada

0 page(s)
January 2024

Req # A-2023-000173

All new records acquired since 2023-12-01 held by Office of the Chief Science Officer (OCSO), Infectious Diseases and Vaccination Programs Branch (IDVPB), and National Microbiology Laboratory Branch (NMLB) at the "team lead" level and above levels mentioning "reverse transcription" in the context of "mRNA". The term "reverse transcription" can be in the context of diagnostic testing and/or research.

Organization: Public Health Agency of Canada

0 page(s)
January 2024

Req # A-2023-000176

Names and total number of all Members of Parliament who received an exemption for the Covid 19 Vaccines from December 14, 2020 to June 14, 2022.

Organization: Public Health Agency of Canada

0 page(s)
January 2024

Req # A-2021-000075

All records pertaining to the initial identification of something other than Creutzfeldt-Jakob Disease (CJD) in possible CJD referral cases in New Brunswick, that something was amiss or something inexplicable was happening. Date range: January 1, 2015 - May 11, 2021.

Organization: Public Health Agency of Canada

114 page(s)
November 2023

Req # A-2021-000365

Documents related to work on the isolation, description, classification and recording of the SARS-Cov-2 virus and its comparison to viruses and pathogens previously studied and referenced by the laboratory. Documents related to the laboratory's development of the reagent for detecting COVID-19 by public health laboratories in Canada. Documents related to the reagent's ability to detect the SARS-Cov-2 virus. Documents related to the laboratory's development of tests for detecting the SARS-Cov-2 virus and/or COVID-19. Documents related the review, analysis, benchmarking, comparison and validation of the various tests for detecting and screening COVID019 authorized by Health Canada, marketed and used across the country to detect COVID-19 and the SARS-Cov-2 virus. Documents related to the review, analysis and ability of diagnostic tests approved by Health Canada to detect the SARS-Cov-2 virus. Documents related to the laboratory's work in examining the correlation between the results of polymerase chain reaction (PCR) tests conducted, the estimation of viral load, the number of amplification cycles needed to detect the virus and the effective and isolated presence of the SARS-Cov-2 virus verified by culturing samples collected from individuals who had a positive result from a diagnostic test approved by Health Canada. Documents related to the laboratory's review, analysis and monitoring of the effectiveness of vaccines used in Canada to prevent and combat COVID-19 and the SARS-Cov-2 virus. Documents, data books and analyses related to the frequency of co-infections in samples collected from people with COVID-19 identified by laboratory culturing. Documents that identify, date and analyze culturing, samples from people declared positive for COVID-19, conducted since the start of 2020 by the laboratory and its annexes and provincial partners.

Organization: Public Health Agency of Canada

1311 page(s)
November 2023
Date modified: